Biocientifica Internacional S D R L Limitada
In 2026, Biocientifica Internacional S D R L Limitada appears as a supplier in 22 records from SICOP firm awards, which amount to 3 unique processes. The most frequent buyer, Caja Costarricense de Seguro Social, accounts for 100% of the records shared with buyers. In Sep 2026, the number of processes is unchanged from Aug 2026. Monetary totals are omitted because the source repeats lifecycle rows for each process.
Create and download this entity’s chart- Source records
- 22
- Sources
- 1
Observed volume
3 processes
22 source rows in SICOP firm awards.
Latest activity
Sep 2026
8 records in the period.
Latest comparable change
No change
Aug 2026 → Sep 2026 · same value
History
Biocientifica Internacional S D R L Limitada: processes by period
Apr 2026–Sep 2026
Relationships
Top counterparties in the records
Ranked by shared record count, without adding different currencies.
Relationship concentration
Reliance on leading counterparties
Each currency is calculated separately. A high share may reflect specialization, scale, or source coverage and is not by itself evidence of misconduct.
Recent activity
Latest published records
Ordered by the most relevant award, publication, or event date in each source. An identical event published by multiple lifecycle sources is shown once and retains every source in the first column. This does not claim the activity happened today.
| Source | Award date | Title | Buyer | Status | Amount | Currency | Fiscal year |
|---|---|---|---|---|---|---|---|
| SICOP firm awards | Sep 10, 2026 | Insumos de Laboratorio Clínico y Medicinas | Caja Costarricense de Seguro Social | Adjudicación firme | $0.18 | USD | 2026 |
| SICOP firm awards | Sep 10, 2026 | Insumos de Laboratorio Clínico y Medicinas | Caja Costarricense de Seguro Social | Adjudicación firme | $0.04 | USD | 2026 |
| SICOP firm awards | Sep 10, 2026 | Insumos de Laboratorio Clínico y Medicinas | Caja Costarricense de Seguro Social | Adjudicación firme | ₡60,500 | CRC | 2026 |
| SICOP firm awards | Sep 10, 2026 | Insumos de Laboratorio Clínico y Medicinas | Caja Costarricense de Seguro Social | Adjudicación firme | ₡48,200 | CRC | 2026 |
| SICOP firm awards | Sep 10, 2026 | Insumos de Laboratorio Clínico y Medicinas | Caja Costarricense de Seguro Social | Adjudicación firme | ₡85,500 | CRC | 2026 |
| SICOP firm awards | Sep 10, 2026 | Insumos de Laboratorio Clínico y Medicinas | Caja Costarricense de Seguro Social | Adjudicación firme | ₡81,500 | CRC | 2026 |
| SICOP firm awards | Sep 10, 2026 | Insumos de Laboratorio Clínico y Medicinas | Caja Costarricense de Seguro Social | Adjudicación firme | ₡63,500 | CRC | 2026 |
| SICOP firm awards | Sep 10, 2026 | Insumos de Laboratorio Clínico y Medicinas | Caja Costarricense de Seguro Social | Adjudicación firme | $38 | USD | 2026 |
| SICOP firm awards | Aug 10, 2026 | Reactivos de bacteriología y otros insumos | Caja Costarricense de Seguro Social | Adjudicación firme | $6.4 | USD | 2026 |
| SICOP firm awards | Apr 10, 2026 | Proceso Licitatorio para la Adquisición de Reactivos Varios para uso en Banco de Sangre | Caja Costarricense de Seguro Social | Adjudicación firme | $138 | USD | 2026 |
| SICOP firm awards | Apr 10, 2026 | Proceso Licitatorio para la Adquisición de Reactivos Varios para uso en Banco de Sangre | Caja Costarricense de Seguro Social | Adjudicación firme | $30 | USD | 2026 |
| SICOP firm awards | Apr 10, 2026 | Proceso Licitatorio para la Adquisición de Reactivos Varios para uso en Banco de Sangre | Caja Costarricense de Seguro Social | Adjudicación firme | $120 | USD | 2026 |
Entity monitoring
Monitor Biocientifica Internacional S D R L Limitada
Get an email when linked records change. Alerts make clear that a change may be new activity, broader coverage, or a source correction.
Coverage and provenance
Sources contributing to this profile
Amounts use multiple currencies or source unit scales and are not added across units.
Procurement histories collapse repeated lifecycle rows when process identifiers are complete and mark incomplete identifiers as approximate.
Headline monetary rollups are omitted because the primary history cannot deduplicate lifecycle snapshots to award-line values safely; source-row counts remain available in provenance.
This profile consolidates source keys within one country and role only through exact identifiers or an unambiguous normalized legal name. Currencies and unit scales remain separate; similar names are not assumed to be the same organization.